According to Astellas Pharma's latest financial reports the company's current EPS (TTM) is $0.41. In 2022 the company made an earnings per share (EPS) of $0.54 a decrease over its 2021 EPS that were of $0.57.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.41 | -23.18% |
2022 | $0.54 | -6% |
2021 | $0.57 | -19.3% |
2020 | $0.71 | -34.26% |
2019 | $1.08 | 8.62% |
2018 | $0.99 | 25.03% |
2017 | $0.79 | -12.88% |
2016 | $0.91 | 28.62% |
2015 | $0.71 | 40.97% |
2014 | $0.50 | -37.66% |
2013 | $0.81 | 132.53% |
2012 | $0.35 | -28.94% |
2011 | $0.49 | 12.47% |
2010 | $0.43 | -27.66% |
2009 | $0.60 |